Short and long period optimization of drug doses in the treatment of AIDS

Anais da Academia Brasileira de Ciencias

Volumn 74, Issue 3, 2002, Pages 379-392

  Caetano, Marco Antonio Leonel ^a   Yoneyama, Takashi ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO TECNOLÓGICO DE AERONÁUTICA   (Brazil)

Author keywords

AIDS; Drugs; Modeling; Simulation; Treatment

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BIOLOGICAL MODEL; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COMPUTER SIMULATION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COMPUTER SIMULATION; HIV; HIV PROTEASE INHIBITORS; HUMANS; LINEAR MODELS; MODELS, BIOLOGICAL; REVERSE TRANSCRIPTASE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036715956     PISSN: 00013765     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0001-37652002000300002     Document Type: Article

References (24)

1. BEHRENS DA, CAULKINS JP, TRAGLER G, HAUNSCHMIED JL AND FEICHTINGER G. 1999. A dynamic model of drug initiation: implications for treatment and drug control. Mathematical Biosciences 159: 1-20.
2. BULIRSH R AND STOER J. 1980. Introduction to Numerical Analysis. Springer-Verlag. 609 p.
3. CAETANO MAL AND YONEYAMA T. 1999a. Comparative Evaluation of Open Loop and Closed Loop Drug Adminstration Strategies in the Treatment of AIDS. An Acad Bras Cienc 71 4-I: 589-597.
4. th ESMTB - Theory and Mathematics in Biology and Medicine, Amsterdam pp. 113-117.
5. th IFAC Symp. Modelling and Control. Greifswald. Germany. 91-96.
6. JACOB HG. 1972. An Engineering Optimization Method with Application to Stol Aircraft Aproach and Landing Trajectories. Langley. NASA TN-D 6978. 38 p.
7. KIRK DE. 1970. Optimal Control Theory: an Introduction. Prentice-Hall. New Jersey. 452 p.
8. KIRSCHNER D AND WEBB GF. 1996. A Model for Treatment Strategy in the Chemotherapy of AIDS. Bull Math Biol 58: 376-390.
9. KIRSCHNER D, LENHART S AND SERBIN S. 1997. Optimal Control of the Chemotherapy of HIV. J Math. Biol 35: 775-792.
10. LEWIS FL. 1986. Optimal Control. John Wiley. New York. 362 p.
11. MITTLER JE, SULZER B, NEUMANN AU AND PERELSON AS. 1998. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Mathematical Biosciences 152: 143-163.
12. MURRAY JM, KAUFMANN G, KELLEHER AD AND COOPER DA. 1998. A Model of primary HIV-1 infection. Mathematical Biosciences 154: 57-85.
13. NOWAK MA AND BANGHAM CRM. 1996. Population Dynamics of Immune Responses to Persistent Viruses. Science 272: 74-79.
14. NOWAK MA, ANDERSON RM, MCLEAN AR, WOLFS TF, GOUDSMIT J AND MAY RM. 1991. Antigenic Diversity Thresholds and the Development of AIDS. Science 254: 963-969.
15. NOWAK MA, MAY RM, PHILLIPS RE, JONES SR, LALLO DG, MCADAMS S, KLENERMAN P. KÖPPE B, SIGMUND K, BANGHAM CRM AND MCMICHAEL AJ. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-611.
16. NOWAK MA, BONHOEFFER S, SHAW GM AND MAY RM. 1997. Anti-viral Drug Treatment: Dynamics of Resistence in Free Virus and Infected Cell Populations. J Theoretical Biology 184: 203-217.
17. +T-cells. Mathematical Biosciences 114: 8-125.
18. PHILLIPS A. 1996. Reduction of HIV Concentration During Acute infection; Independence from a Specific Immune Response. Science 271: 497-499.
19. PONTESILLI O, KERKHOF-GARDE S, PAKKER NG, NOTERMANS DW, ROOS MTL, KLEIN MR, DANNER SA AND MIEDEMA F. 1999. Immunology Letters 66: 213-217.
20. + T-Cell Infection by HIV and Some Monte Carlo Studies. Mathematical Biosciences 147: 173-205.
21. TAN WY AND XIANG Z. 1999. Some state space models of HIV pathogenesis under treatment by anti-viral drugs in HIV-infected individuals. Mathematical Biosciences 156: 69-94.
22. WEIN LM, D'AMATO RM AND PERELSON A. 1998. Mathematical Analysis of Antiretroviral Therapy Aimed at HIV-1 Eradication or Maintenance of Low Viral Loads. J Theoretical Biology 192: 81-98.
23. WICK D. 1999. On T-cell dynamics and the hyperactivation theory of AIDS pathogenesis. Mathematical Biosciences 158: 127-144.
24. ZARIC GS, BAYOUMI AM. BRANDEAU ML AND OWENS DK. 1998. The Effects of Protease inhibitors on the Spread of HIV and Development of Drug-Resistant HIV Strains: A Simulation Study. Simulation 71: 262-275.